Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "methodist hospital" | Open Studies | "Fibrosis" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
2 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.